MedPath

The effect of exercise in the treatment of polycystic ovary syndrome

Not Applicable
Conditions
Polycystic Ovary Syndrome.
Polycystic ovarian syndrome
Registration Number
IRCT201212127255N4
Lead Sponsor
Investigator
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
40
Inclusion Criteria

age range 16 to 40 years; body mass index less than 20 and more than 25; at least two of the symptoms of PCOS; no ovulation or oligomenorrhea; hirsutism (above 8) and clinical or biochemical hyperandrogenism; Exclusion criteria: Patients undergoing treatment for menstrual disorders; antiepileptic drugs; contraceptives; pregnancy or weight loss drugs; those with hepatitis; pulmonary-cardiac disorders; diabetes; pregnancy; hypo-and hyperthyroidism Cushing's syndrome and adrenal hyperplasia.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood Prolactin. Timepoint: Before and after of intervention. Method of measurement: By method of chemoluminescence using Liaison kit.;Blood Testosterone. Timepoint: Before and after intervention. Method of measurement: By Elisa kit of ROTH.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath